Marinus Pharmaceuticals reported 11.74M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
ALKERMES ALKS:US 150.38M 5.32M
Amgen AMGN:US $ 1.33B 99M
Biogen BIIB:US $ 572.6M 62.3M
Eisai 4523:JP 92.31B 18.18B
Enanta Pharmaceuticals ENTA:US $ 12.93M 2.45M
Esperion Therapeutics ESPR:US $ 29.61M 772K
Gilead Sciences GILD:US $ 1.36B 274M
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
Intra Cellular Therapies ITCI:US $ 100.32M 24.86M
Marinus Pharmaceuticals MRNS:US 11.74M 1.12M
Minerva Neurosciences NERV:US $ 2.83M 196.19K
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Ptc Therapeutics PTCT:US $ 79.89M 6.62M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Supernus Pharmaceuticals SUPN:US $ 100.48M 10.02M
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K
YTE INCY:US $ 253.28M 43.69M